These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. US Supreme Court applies strict limits to patents. Robertson D Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532 [No Abstract] [Full Text] [Related]
71. US Supreme Court decision could compromise biotech patents. Robertson D Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981 [No Abstract] [Full Text] [Related]
72. Patents on parts of the human body: salient issues under EC and WTO law. Herdegen M J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546 [No Abstract] [Full Text] [Related]
73. Biotech in post-TRIPS India. Ramani SV; Pradhan P; Ravi M Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608 [No Abstract] [Full Text] [Related]
74. Super-enzyme patents get their day in court. Cyranoski D Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315 [No Abstract] [Full Text] [Related]
75. When the human genome project and state street collide. Locke SD; Kalow DA Nat Biotechnol; 2000 Sep; 18(9):1009-10. PubMed ID: 10973226 [No Abstract] [Full Text] [Related]
76. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution. New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531 [No Abstract] [Full Text] [Related]
78. Opinions evolve on Kauffman patent. Dove A Nat Biotechnol; 2000 Apr; 18(4):373. PubMed ID: 10748506 [No Abstract] [Full Text] [Related]
79. The MTA-rip it up and start again? Ku K; Henderson J Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290 [No Abstract] [Full Text] [Related]